|
May 13
|
Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry
|
|
May 12
|
Cathie Wood Is Buying This Under-the-Radar AI Stock
|
|
May 11
|
Recursion Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
|
|
May 10
|
Recursion Pharmaceuticals Inc (RXRX) Q1 2024 Earnings: Revenue Surpasses Estimates Amid ...
|
|
May 10
|
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Recursion Pharmaceuticals (RXRX) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 9
|
Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results
|
|
May 3
|
Recursion Pharmaceuticals (RXRX) Increases Yet Falls Behind Market: What Investors Need to Know
|
|
May 2
|
Recursion Pharmaceuticals, Inc. (RXRX) is Attracting Investor Attention: Here is What You Should Know
|
|
May 2
|
Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9
|
|
Apr 30
|
Jim Cramer is Recommending These 10 Stocks Heading Into May 2024
|
|
Apr 30
|
Altitude Lab Secures Small Business Administration Growth Fund Accelerator Grant to Launch Horizon, a Commercialization Partnering Program
|
|
Apr 27
|
Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves
|
|
Apr 27
|
The Top 3 Biotech Stocks to Buy in April 2024
|
|
Apr 25
|
Recursion Pharmaceuticals (RXRX) Declines More Than Market: Some Information for Investors
|
|
Apr 25
|
3 Millionaire-Maker Biotech Stocks
|
|
Apr 17
|
Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know
|
|
Apr 17
|
Where Will Recursion Pharmaceuticals Be in 5 Years?
|
|
Apr 16
|
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
|
|
Apr 15
|
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
|